Top Cytokinetics Executive Makes Notable Stock Move in High-Value SaleTip Ranks·17 hours agoCYTK-2.43%
Cytokinetics EVP R&D Malik Fady Ibraham disposes of common shares worth $239,015PUBT·21 hours agoCYTK-2.43%
Here’s How Much You Would Have Made Owning Cytokinetics Stock In The Last 15 Yearsbenzinga_article·2 days ago, 03:45 PMCYTK-2.43%
Weekly Recap | Cytokinetics -6.76%, underperforms the marketWeekly Review·Sep 19 at 05:51 AMCYTK-2.43%
Cytokinetics grants 52,834 inducement stock options at USD 69.31 strike pricePUBT·Sep 17 at 08:00 PMCYTK-2.43%
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant ProgramUnusual Whales·Sep 14 at 11:31 AMCYTK-2.43%
Cytokinetics (CYTK) Shares In Focus After New Phase 3 Aficamten DataSimplywall·Sep 12 at 08:26 PMCYTK-2.43%
Cytokinetics director Robert E. Landry sells 1,000 common shares worth $74,660PUBT·Sep 11 at 11:13 PMCYTK-2.43%
If You Invested $1000 In Cytokinetics Stock 10 Years Ago, You Would Have This Much Todaybenzinga_article·Sep 11 at 03:45 PMCYTK-2.43%
CYTK: MYQORZO drives growth with strong launches, robust pipeline, and expanding global reachQuartr·Sep 9 at 07:10 PMCYTK-2.43%
The great biotech reshuffle: AI bets, survival pivots, and buyout rumorsGlobal Report·Sep 9 at 10:11 AMJAZZ-2.44%BCAB-18.08%
Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $264,110PUBT·Sep 8 at 08:39 PMCYTK-2.43%
ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsybiopharmadive·Sep 3 at 03:25 PMCYTK-2.43%ARWR-5.89%
Cytokinetics to Participate in September Investor ConferencesUnusual Whales·Sep 2 at 08:01 PMCYTK-2.43%
Cytokinetics management to join Citi BioPharma investor conference fireside chatPUBT·Sep 2 at 08:00 PMCYTK-2.43%C-0.09%
